The ₹5,50,08,874 grant, awarded for four years, will support the ADAPT-EB project — Developing Accessible Diagnostics and Affordable Precision Therapies for Epidermolysis Bullosa in the Indian population.
Read full story at India Latest News: Top National Headlines Today & Breaking News | The Hindu ↗